Manuscript
Development of a dynamic risk prediction tool for identifying individuals at high risk of cardiovascular diseases: A post-hoc analysis of the multi-ethnic study of atherosclerosis
Abderrahim Oulhaj et al.
Atherosclerosis 2026;421:121877
Manuscript
Serial Assessment of NT-proBNP and High-Sensitivity Cardiac Troponin with Glucagon-Like Peptide-1 Receptor Agonist Therapy in Type 2 Diabetes: Insights from EXSCEL
Veraprapas Kittipibul et al.
Am Heart J. 2026;299:107475
Manuscript
A Validated, Modifiable Proteomic Score from the EXSCEL Trial Predicts Cardiovascular Events in Diabetes.
Corey KM et al.
JCI Insight. 2026;11:e204463
Manuscript
Semaglutide treatment fails but might prevent Alzheimer's disease
Ivan Koychev et al.
Lancet 2026;408:602-603
Manuscript
To cluster or not to cluster? A comparison of approaches to targeting type 2 diabetes glucose lowering therapy in the TRIMASTER Crossover Trial
Güdemann LM et al.
Diabetes Care 2026;49:1458-1466
Manuscript
Leveraging External Controls in Clinical Trials: Estimands, Estimation, Assumptions
Bo Liu et al.
J Biopharm Stat. 2026